DEBITO Cambiamento Data
AbbVie USD 70.82B 2.04B 2026-06
Amgen USD 57.3B 19M 2026-06
AstraZeneca USD 32.24B 1.68B 2026-06
Biogen USD 7.69B 398.3M 2026-09
Bristol-Myers Squibb USD 42.88B 2.18B 2026-09
Daiichi Sankyo JPY 500.48B 200B 2026-06
Eli Lilly USD 54.91B 11.54B 2026-06
Genmab DKK 5.35B 5.2B 2026-03
Geron USD 122.14M 78K 2026-06
Gilead Sciences USD 26.25B 4.07B 2026-06
J&J USD 49.04B 5.95B 2026-06
Karyopharm Therapeutics USD 299.23M 35.14M 2025-12
MacroGenics USD 35.09M 1.42M 2026-06
Merck USD 53.91B 4.79B 2026-06
Pfizer USD 62.67B 523M 2026-09
Puma Biotechnology USD 89.06M 55.07M 2024-06
Regeneron Pharmaceuticals USD 2.71B 400K 2026-06
Roche Holding CHF 33.03B 1.41B 2025-06
Xencor USD 170.11M 5.06M 2026-06